These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 25979385)
1. [Are anti-TNF-α agents really useful in systemic vasculitis? Experience in polyarteritis nodosa]. Núñez Cuadros E; Galindo Zavala R; Díaz Cordovés-Rego G; Vera Casaño A; Urda Cardona AL An Pediatr (Barc); 2015 Nov; 83(5):350-2. PubMed ID: 25979385 [No Abstract] [Full Text] [Related]
2. Polyarteritis Nodosa with a Systemic Inflammatory Response Pattern: Effectiveness of anti-TNF. Tous-Romero F; Rodríguez-Almaraz E; Rodríguez-Peralto JL; Postigo-Llorente C Actas Dermosifiliogr; 2017 Oct; 108(8):787-790. PubMed ID: 28372782 [No Abstract] [Full Text] [Related]
3. Cutaneous polyarteritis nodosa in pediatric patients successfully treated with TNF-α inhibitor and methotrexate: Case series and literature review. Do N; Ringold S; Brandling-Bennett H Pediatr Dermatol; 2019 Nov; 36(6):932-935. PubMed ID: 31576593 [TBL] [Abstract][Full Text] [Related]
5. Infliximab in a child with therapy-resistant systemic vasculitis. de Kort SW; van Rossum MA; ten Cate R Clin Rheumatol; 2006 Sep; 25(5):769-71. PubMed ID: 16267606 [TBL] [Abstract][Full Text] [Related]
7. What is the evidence for prophylactic antibiotic treatment in patients with systemic vasculitides? Kallenberg CG Curr Opin Rheumatol; 2011 May; 23(3):311-6. PubMed ID: 21346576 [TBL] [Abstract][Full Text] [Related]
8. Young male patient diagnosed with cutaneous polyarteritis nodosa successfully treated with etanercept. Valor L; Monteagudo I; de la Torre I; Fernández CG; Montoro M; Longo JL; Carreño L Mod Rheumatol; 2014 Jul; 24(4):688-9. PubMed ID: 24981320 [TBL] [Abstract][Full Text] [Related]
9. HIV infection and clinical spectrum of associated vasculitides. Patel N; Patel N; Khan T; Patel N; Espinoza LR Curr Rheumatol Rep; 2011 Dec; 13(6):506-12. PubMed ID: 21989711 [TBL] [Abstract][Full Text] [Related]
10. Adalimumab therapy in hepatitis B virus-negative polyarteritis nodosa: A case report. Wang CR; Yang CC Medicine (Baltimore); 2018 Jun; 97(25):e11053. PubMed ID: 29923995 [TBL] [Abstract][Full Text] [Related]
11. Biologic therapy in ANCA-negative vasculitis. Loricera J; Blanco R; Hernández JL; Pina T; González-Vela MC; González-Gay MA Int Immunopharmacol; 2015 Aug; 27(2):213-9. PubMed ID: 25828585 [TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor blockade in the management of children with orphan diseases. Brik R; Gepstein V; Shahar E; Goldsher D; Berkovitz D Clin Rheumatol; 2007 Oct; 26(10):1783-5. PubMed ID: 17219021 [TBL] [Abstract][Full Text] [Related]
13. [Polyarteritis Nodosa, a vanishing vasculitis since its main cause has been identified]. Frey FJ Ther Umsch; 2008 May; 65(5):247-51. PubMed ID: 18622927 [TBL] [Abstract][Full Text] [Related]
14. Successful treatment of tumor necrosis factor inhibitor-resistant cutaneous polyarteritis nodosa with tocilizumab. Inoue N; Shimizu M; Mizuta M; Yachie A Pediatr Int; 2020 Jun; 62(6):753-755. PubMed ID: 32515121 [No Abstract] [Full Text] [Related]
15. Systemic vasculitis and the gut. Hatemi I; Hatemi G; Çelik AF Curr Opin Rheumatol; 2017 Jan; 29(1):33-38. PubMed ID: 27684357 [TBL] [Abstract][Full Text] [Related]
16. [Systemic vasculitis: study of 27 cases in Senegal]. Ndongo S; Diallo S; Tiendrebeogo J; Diop IB; Tall A; Pouye A; Ka MM; Diop TM Med Trop (Mars); 2010 Jun; 70(3):264-6. PubMed ID: 20734595 [TBL] [Abstract][Full Text] [Related]
17. Polyarteritis (periarteritis) acuta nodosa. PAGE AP Med Press; 1947 Nov; 218(22):487-90. PubMed ID: 18896166 [No Abstract] [Full Text] [Related]
18. Inflammatory Comments in Coronary Artery Disease: When to Suspect Polyarteritis Nodosa or Other Primary Systemic Vasculitis. Xie Y; Seidman MA Can J Cardiol; 2021 Jun; 37(6):830-832. PubMed ID: 33453354 [No Abstract] [Full Text] [Related]